Most VCs cannot stomach the long road to a nanotech payoff.
|
Sign on the dotted line--unless you're hiding something.
|
Drug makers need a cure for the manufacturing crunch.
|
Venture capital firms continue to raise billion-dollar funds at a time when some of them are too busy to even hear new pitches. What gives?
|
800.com leads battle against Xmas crunch
|